J. Jeffrey Goater
2018
In 2018, J. Jeffrey Goater earned a total compensation of $4.7M as Chief Executive Officer, President and Director at Surface Oncology, a 236% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $219,500 |
|---|---|
| Option Awards | $4,077,144 |
| Salary | $429,000 |
| Other | $10,121 |
| Total | $4,735,764 |
Goater received $4.1M in option awards, accounting for 86% of the total pay in 2018.
Goater also received $219.5K in non-equity incentive plan, $429K in salary and $10.1K in other compensation.
Rankings
In 2018, J. Jeffrey Goater's compensation ranked 2,169th out of 14,244 executives tracked by ExecPay. In other words, Goater earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,169 out of 14,244 | 85th |
Division Manufacturing | 787 out of 5,765 | 86th |
Major group Chemicals And Allied Products | 265 out of 2,128 | 88th |
Industry group Drugs | 213 out of 1,817 | 88th |
Industry Biological Products, Except Diagnostic Substances | 44 out of 339 | 87th |
Source: SEC filing on April 19, 2019.
Goater's colleagues
We found two more compensation records of executives who worked with J. Jeffrey Goater at Surface Oncology in 2018.